Advertisement
Corona VirusEuropeUnited Kingdom (UK)

COVID-19: UK administers life-saving drugs with immediate effect

By Oluwaseun Sonde

Spread the love

The United Kingdom Government has administered life-saving drugs in its National Health Scheme NHS settings with immediate effect, as patients in intensive care units are to receive potentially life-saving treatment for COVID-19.

In a statement released by the UK Government on Thursday, this life-saving treatment can reduce the time spent in hospital by up to 10 days, as announced by the Government, which will significantly reduce pressure on hospitals.

“According to the results from the Government-funded REMAP-CAP clinical trial published today showed tocilizumab and sarilumab reduced the relative risk of death by 24%, when administered to patients within 24 hours of entering intensive care.

“Most data came from when the drugs were administered in addition to a corticosteroid, such as dexamethasone also discovered through government-backed research through the RECOVERY clinical trial which is already provided as standard of care to the NHS”.

Moreso, patients receiving these drugs, typically used to treat rheumatoid arthritis, left intensive care between 7 to 10 days earlier on average, while the rollout of these treatments could therefore contribute significantly towards reducing pressures on hospitals over the coming weeks and months.

Furthermore, updated guidance will be issued tomorrow by the government and encouraging them to use tocilizumab in their treatment of COVID-19 patients who are admitted to intensive care units, effective immediately.

“Supplies of tocilizumab are already available in hospitals across the UK and clinicians will be able to treat all those admitted to intensive care units, potentially saving hundreds of lives”, as stated.





Spread the love
Advertisement
Show More
Back to top button
DE HONEY MONTESSORI SCHOOL
Close
Close